Nouf Alluqmani
Ottawa, ON K1H8M5, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy.
Journal: Nature communications
Published: October 12, 2023
A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection.
Journal: Molecular therapy. Methods & clinical development
Published: May 02, 2023
Syngeneic mouse model of human HER2+ metastatic breast cancer for the evaluation of trastuzumab emtansine combined with oncolytic rhabdovirus.
Journal: Frontiers in immunology
Published: March 06, 2023
CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX.
Journal: Frontiers in immunology
Published: September 21, 2022
Vanadyl sulfate-enhanced oncolytic virus immunotherapy mediates the antitumor immune response by upregulating the secretion of pro-inflammatory cytokines and chemokines.
Journal: Frontiers in immunology
Published: August 30, 2022
Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer.
Journal: Frontiers in immunology
Published: August 27, 2022
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 18, 2022
Dependency of EGFR activation in vanadium-based sensitization to oncolytic virotherapy.
Journal: Molecular therapy oncolytics
Published: November 13, 2021
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy.
Journal: Nature communications
Published: November 11, 2021
Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: November 17, 2020
The strategic combination of trastuzumab emtansine with oncolytic rhabdoviruses leads to therapeutic synergy.
Journal: Communications biology
Published: September 05, 2019
Galectin-9 binds IgM-BCR to regulate B cell signaling.
Journal: Nature communications
Published: December 13, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026